Oral & Salivary Cancer Biology Program

The Oral and Salivary Cancer Biology Program supports basic and translational research to improve detection and treatment of cancers of the Oral Cavity, Pharynx, and Salivary Glands. Basic research focuses on susceptibilities and mechanisms that influence tumor initiation, promotion, and progression. Translational research focuses on development of innovative biomarkers, novel diagnostic technologies, and appropriate human specimens to better characterize cancers and improve medical decision making and treatment response evaluation.

Staff Contacts

Funding Opportunity Announcements

Title Staff contact Opportunity number Activity Code Application due date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) PA-18-906 C06, D43, D71
Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed) RFA-RM-18-036 U01
Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed) RFA-RM-18-028 UG3, UH3
Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed) RFA-RM-18-027 UG3, UH3
Limited Competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed) RFA-RM-18-026 D71, U54
Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed) RFA-RM-18-025 D71, UG3, UH3
Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed) RFA-RM-18-024 D71, U01
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) RFA-RM-18-023 UG3, UH3
Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed) RFA-RM-18-022 D71, U01
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) PAR-18-848 R21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) PAR-18-846 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) PAR-18-845 R01
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-18-837 R41, R42, R43
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional) RFA-TR-18-020 U54
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) PA-18-817 C06
Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed) PAR-18-788 D71, R21
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional) RFA-RM-18-009 D71, R01
NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional) RFA-RM-18-008 DP2
Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) PAR-18-787 R01
Biology of Lung, and Head and Neck Preneoplasias (R21 - Clinical Trial Not Allowed) 17-460 R21
Biology of Lung, and Head and Neck Preneoplasias (R01- Clinical Trial Not Allowed) PA-17-459 R01
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) PA-18-739 R21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) PA-18-738 R01
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) PA-18-713 C06, D43, D71
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional) PA-18-658 DP1, DP2, DP4
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-18-576 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-18-575 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-18-574 R43, R44
Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional) PAR-18-646 U01
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-18-648 R13
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) PAR-18-313 P50
Administrative Supplements for Research on Dietary Supplements (Admin Supp) PA-17-307 P30, P40, P50
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) PAR-18-009 R01
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-18-530 R01
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) PA-18-504 R15
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-18-489 R21
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) PAR-17-476 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) PAR-17-475 R21
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) PA-17-239 R01
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) PA-16-295 R01
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) PA-16-296 R21
Tools for Cell Line Identification (R43/R44) PA-16-186 R43, R44
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) PA-17-148 R41, R42
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) PAR-15-344 R03
Change of Grantee Organization (Type 7 Parent) PA-16-285 C06, D43, D71
Successor-in-Interest (Type 6 Parent) PA-16-286 C06, D43, D71
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) PA-16-289 DP1, DP2, DP3
NIDCR Small Grant Program for New Investigators (R03) PAR-16-409 R03
SBIR Technology Transfer (R43/R44) PA-15-354 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44) PA-16-180 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42) PA-16-181 R41, R42
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) PA-17-147 R43, R44
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) PAR-17-243 R21